Modeling microbial drug-resistance: from mathematics to pharmacoeconomics

Modeling microbial drug-resistance: from mathematics to pharmacoeconomics

Complicated intra-abdominal infection (IAI) requires increased health care expenditures and additional resources to compensate for an ineffective starting therapy.Aim. To select the economically optimal algorithm for using antimicrobial agents (AMA) that would minimize the evolving drug-resistance o...

Full description

Bibliographic Details
Main Authors:	Yu. M. Gomon, M. A. Arepyeva, Yu. E. Balykina, A. S. Kolbin, A. A. Kurylev, M. A. Proskurin, S. V. Sidorenko
Format:	Article
Language:	Russian
Published:	IRBIS LLC 2018-05-01
Series:	Фармакоэкономика
Subjects:	mathematic modeling drug-resistance antimicrobial medication complicated intra-abdominal infections
Online Access:	https://www.pharmacoeconomics.ru/jour/article/view/227

Similar Items

PROBLEMS OF COMPLICATED INTRA-ABDOMINAL INFECTION’S ANTIBACTERIAL TREATMENT IN MULTIDISCIPLINARY HOSPITALS
by: Yu. M. Gomon, et al.
Published: (2017-12-01)

Calculation of the optimal structure of antibiotic consumption in a hospital based on the predicted antimicrobial resistance in the treatment of uncomplicated acute pyelonephritis
by: Gomon Yu.M., et al.
Published: (2018-08-01)

Pharmacoeconomic analysis of denosumab in patients with breast cancer and bone metastases
by: A. S. Kolbin, et al.
Published: (2018-05-01)

Antimicrobial drug consumption in the Russian Federation (2008–2022): pharmacoepidemiological study
by: Gomon Yu.M., et al.
Published: (2023-12-01)

Efficacy of alectinib in comparison with lorlatinib in patients with ALK-positive non-small cell lung cancer: pharmacoeconomic study
by: A. S. Kolbin, et al.
Published: (2023-11-01)

Pharmacoeconomic analysis of vemurafenib and dabrafenib use in patients with inoperable or metastatic melanoma with BRAF V600 mutation
by: A. S. Kolbin, et al.
Published: (2018-05-01)

Pharmacoeconomic evaluation of ipragliflozin in combination with metformin in comparison with other regimens of therapy for type 2 diabetes mellitus
by: A. S. Kolbin, et al.
Published: (2021-02-01)

An update of pharmacoeconomic analysis of trastuzumab emtanzine in patients with HER2+ breast cancer and central nervous system metastases
by: A. S. Kolbin, et al.
Published: (2019-04-01)

ANALYSIS OF CONSUMPTION OF ANTIBACTERIAL DRUGS FOR SYSTEMIC USE IN HOSPITALS OF SAINT PETERSBURG IN 2014–2015
by: Yu. M. Gomon, et al.
Published: (2018-10-01)

Pharmacoeconomic analysis of trastuzumab emtanzine comparing to lapatinib + capecitabine in pa-tients with HER2+ breast cancer and central nervous system metastases
by: A. S. Kolbin, et al.
Published: (2018-05-01)

Pharmacoeconomic analysis of the use of botulinum toxin in the treatment of poststroke spasticity
by: A. S. Kolbin, et al.
Published: (2018-05-01)

PHARMACOECONOMIC ANALYSIS OF MICAFUNGIN USING IN THE TREATMENT OF INVASIVE CANDIDIASIS IN NEWBORNS
by: A.S. Kolbin, et al.
Published: (2011-08-01)

PHARMACOECONOMIC ANALYSIS OF MICAFUNGIN USING IN THE TREATMENT OF INVASIVE CANDIDIASIS IN NEWBORNS
by: A.S. Kolbin, et al.
Published: (2011-08-01)

Pharmacoeconomic evaluation of mirabegron: results of the healthcare budget impact analysis
by: A. S. Kolbin, et al.
Published: (2018-06-01)

Pharmacoeconomic analysis of botulinum toxin in complex therapy for cerebral palsy
by: A. S. Kolbin, et al.
Published: (2018-06-01)

Pharmacoeconomical analysis of use of the low-molecular weight heparins for prevention of the venous tromboembolism in the conditions of multidisciplinary hospital
by: A. S. Kolbin, et al.
Published: (2015-03-01)

Analysis of effectiveness criteria in pharmacoeconomic studies of antimicrobial agents proposed for inclusion in the Russian essential drug list in the 2014 -2016
by: Gomon Yu.M., et al.
Published: (2017-08-01)

HEALTH ECONOMIC ASSESSMENT OF ANTIRHEUMATIC DRUGS IN PATIENTS WITH REUMATHOID ARTHRITIS PROGRESSED AFTER METOTREXATE
by: A. S. Kolbin, et al.
Published: (2016-12-01)

Using indirect comparisons in pharmacoeconomic examination
by: Yu. E. Balykina, et al.
Published: (2015-03-01)

Pharmacoeconomic analysis of Flemoclav Solutab® use in adult patients with acute sinusitis in routine outpatient clinical practice in Russia
by: A. S. Kolbin, et al.
Published: (2018-05-01)

Pharmacoeconomic analysis of the use of ibrutinib in therapy of the first line of a chronic lymphocytic leukaemia for patients with 17p deletion
by: A. S. Kolbin, et al.
Published: (2018-05-01)

Epidemiological Characteristics, Antimicrobial Susceptibility Profile, and Surgical Outcome of Complicated Intra-Abdominal Infection at a Tertiary Hospital in Somalia
by: Yasin NA, et al.
Published: (2022-09-01)

PHARMACOECONOMIC ANALYSIS OF THE USE OF RIBOMUSTIN® IN THERAPY OF THE FIRST LINE OF A MULTIPLE MYELOMA FOR PATIENTS MORE SENIOR 65 YEARS OLD
by: A. S. Kolbin, et al.
Published: (2015-03-01)

Pharmacoeconomic analysis of fixed-duration targeted therapy regimens for chronic lymphocytic leukemia compared with therapy used until progression or intolerable toxicity
by: A. R. Kasimova, et al.
Published: (2022-11-01)

Pharmacoeconomics modes of antibiotic therapy of uncomplicated community-acquired acute pyelonephritis in a multidisciplinary hospital
by: Y. M. Gomon, et al.
Published: (2019-01-01)

The socioeconomic burden of meningococcal infection in the Russian Federation
by: Yu. V. Lobzin, et al.
Published: (2024-12-01)

A Proposal for a Classification Guiding the Selection of Appropriate Antibiotic Therapy for Intra-Abdominal Infections
by: Massimo Sartelli, et al.
Published: (2022-10-01)

Pharmacoeconomic assessment of antipsychotic treatment in outpatients with schizophrenia
by: I. A. Vilyum, et al.
Published: (2018-05-01)

Intra‐abdominal hemorrhage as a rare complication of endoscopic ultrasonography: A case report
by: Kazunaga Ishigaki, et al.
Published: (2022-04-01)

Abandoning the blind legacy passed on horde of routine intra-abdominal drain insertion in cesarean section
by: Kamil Fram, et al.
Published: (2020-04-01)

PHARMACOECONOMIC ANALYSIS OF BRENTUXIMAB VEDOTIN THERAPY IN RELAPSED OR REFRACTORY CD30+ SYSTEMIC ANAPLASTIC LARGE CELL LYMPHOMA IN PATIENTS OVER 18 YEARS OF AGE: HEALTH BUDGET IMPACT ANALYSIS
by: A. S. Kolbin, et al.
Published: (2017-05-01)

ANAESTHETIC ASPECTS OF IMPROVING CONDITIONS OF ENDOSCOPIC GASTRECTOMY IN PATIENTS WITH MORBID OBESITY
by: M. I. Neimark, et al.
Published: (2018-08-01)

Analysis of effectiveness criteria in pharmacoeconomic studies of hypoglycemic drugs proposed for inclusion into the essential drug list in 2014-2016 in Russia
by: A. A. Mosikyan, et al.
Published: (2018-05-01)

Pharmacoeconomic analysis of using typical and atypical antipsychotics in schizophrenia
by: I. A. Vilyum, et al.
Published: (2018-08-01)

Consensus Recommendations Based on Evidence for Abdominal Sepsis in the Pediatric and Adult Population of Colombia
by: Jose Oñate
Published: (2021-04-01)

Laparoscopic treatment of appendiceal peritonitis without drainage in children—A prospective randomized clinical trial
by: Hoang Viet Tran, et al.
Published: (2023-10-01)

Comparison of Primary Outcomes in Extra-Abdominal Versus Intra-Abdominal Uterine Repair at Caesarean Section: A Comparative Study
by: Sanum Kashif, et al.
Published: (2022-04-01)

Health economic evaluation of risdiplam in patients with spinal muscular atrophy
by: А. S. Kolbin, et al.
Published: (2021-10-01)

PREVENTION AND TREATMENT OF INTRAABDOMINAL HYPERTENSION IN PATIENTS WITH PATHOLOGY OF ABDOMINAL ORGANS
by: A. Kolosovych
Published: (2016-04-01)

Measurement of Intra-abdominal Pressure in Critically-ill Children
by: Jyoti Singhal, et al.
Published: (2014-12-01)